Healthtech Startups

MPA Pharma is a pharmaceutical company that manufactures and distributes generic and branded medicines. The company operates across multiple business areas in the healthcare sector.

1 investor

mPATH Health develops an SMS-based behavioral science platform that guides patients through cancer screening decisions and increases completion rates across lung, breast, and colorectal screening programs. The platform serves health systems and Federally Qualified Health Centers (FQHCs) to automate patient navigation at scale.

1 investor

M&Q Packaging manufactures specialized plastic films and bags, including vacuum bagging films for composites, sterilization films for medical/dental applications, solvent recovery liners, and modified atmosphere packaging (MAP) films for fresh produce. The company serves manufacturing, medical, dental, food packaging, and cleanroom industries.

1 investor

mRelief is a nonprofit that operates a web and text-messaging platform (via shortcode 74544) to help Americans check their likely eligibility for SNAP benefits and sign up. It uses USDA public datasets on BBCE and COVID-19 Waivers and covers all 50 states and DC.

1 investor

MSD is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.

1 investor

MSG is a German service partner and official factory service for Ackermann by Honeywell nurse call systems, offering modernization, maintenance, repairs, spare parts, and consulting. It serves hospitals and care facilities across Germany as the country's largest dealer for these call systems.

1 investor

MS Pen Technologies develops molecular data analysis tools for use by researchers, surgeons, and clinicians at the point of care to improve patient outcomes. The company operates in the medical device and surgical technology sector.

1 investor

mTilda provides a Laboratory Information Management System (LIMS) for HLA laboratories, offering data management, analysis tools, and EMR integration. The company serves histocompatibility and immunogenetics labs with custom software solutions and implementation support.

1 investor

Mountain Group Partners is a venture capital firm with 25 years of history that invests in disruptive technologies, diagnostics, medtech, animal health, and drug development across underserved sectors. The firm operates with a long-term investment horizon and an operator-focused approach, maintaining significant co-investment in its funds.

1 investor

MucoLife Therapeutics develops treatments for pulmonary mucus obstruction associated with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Its lead product is a mucus modulator designed to dissolve mucus plugs obstructing the airways.

1 investor

Multiball is an early-stage venture capital firm that provides seed capital to founders building companies in healthcare, aerospace and defense, and advanced manufacturing. Its portfolio spans areas such as counter-drone systems, defense forecasting AI, space infrastructure financing, and offensive cybersecurity.

1 investor

multimmune develops cancer diagnostics and therapeutics ("theranostics") based on membrane Hsp70, a molecule expressed across many cancer types. Its work spans therapeutic interventions, drug targeting strategies, diagnostic tools, and imaging platforms within precision oncology.

1 investor

Multisorb develops and manufactures moisture and oxygen control solutions, including desiccants and oxygen absorbers, for packaging applications in healthcare, pharmaceutical, industrial, and military sectors. The company provides customized solutions, simulation testing, and equipment design to help manufacturers protect products throughout their supply chain.

1 investor

Multiwave develops portable MRI scanners using metamaterials and artificial intelligence to make medical imaging more accessible and affordable. The company collaborates with academic institutions and medical centers on next-generation imaging technologies for early diagnosis and preventive care.

1 investor

The page discusses Age Related Macular Degeneration (AMD), a major cause of sight loss in people over 50 in the developed world, covering its types, symptoms, and public health impact rather than describing a company's products or services.

1 investor

Mumbai Mobile Creches provides childcare and early childhood education services for children of construction workers and migrant laborers in India. The organization operates day-care centers at construction sites and conducts training programs for caregivers and community members.

1 investor

mumms Software builds Hummingbird, an EMR and workflow platform purpose-built for hospice and palliative care providers. The system covers hospice-specific documentation, IDG meetings, physician order signing, medication management, per diem billing, and compliance for interdisciplinary care teams.

1 investor

Mútua Portuguesa de Saúde (MPS) is a mutual insurance cooperative offering health insurance to workers in the public, private, and social sectors in Portugal, with premiums proportional to income and no age limits, waiting periods, or pre-existing condition exclusions. Employers enroll their staff, who access care through the Future Healthcare medical network or free-choice reimbursement, managed via the MyMPS digital platform.

1 investor

AutoScribe is an AI-powered digital assistant developed by Mutuo Health Solutions that automates clinical documentation to reduce administrative burden on healthcare providers. The company, based in Toronto, serves physicians and healthcare practitioners in Canada.

1 investor

MVM is a healthcare-focused investment firm that provides growth equity to companies in medical technology, pharmaceuticals, diagnostics, digital health, life science tools, and contract research and manufacturing. Operating from Boston and London since 1997, it partners with management teams to scale differentiated healthcare products across global markets.

1 investor

MVSystem develops software solutions for healthcare facilities, including documentation, telemedicine, remote equipment management, and patient monitoring systems. The company serves clinics and hospitals primarily in Russia.

1 investor

MVT in Silico develops computational platforms and simulation tools for drug discovery and biomedical research, enabling researchers to predict therapeutic effects and optimize drug development. The company serves pharmaceutical and biotechnology firms seeking to reduce late-stage development failures through model-informed drug development and in silico modeling.

1 investor

MVT Pharma develops ultrasound contrast agents and theranostics to advance imaging and treatment capabilities. The company focuses on drug discovery and development in medical imaging and oncology.

1 investor

MX Labs develops an AI-powered health monitoring platform that measures 30+ vital signs through facial recognition technology using any standard camera, targeting healthcare providers and insurance companies. The system performs real-time analysis on the user's device without requiring external hardware or cloud processing.

1 investor